VWF and platelet-type von Willebrand disease: Numerous approaches including genetically modified mouse models, various forms of von Willebrand disease, shear-induced thrombus formation, specific interactions with isolated A1 domain, etc. have been used for the characterization of vWF-induced signaling [28].